Hawaii Revised Statutes
329. Uniform Controlled Substances Act
329-20 Schedule IV.

§329-20 Schedule IV. (a) The controlled substances listed in this section are included in schedule IV.
(b) Depressants. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, esters, ethers, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, that has a degree of danger or probable danger associated with a depressant effect on the central nervous system:
(1) Alprazolam;
(2) Barbital;
(3) Bromazepam;
(4) Butorphanol;
(5) Camazepam;
(6) Carisoprodol;
(7) Chloral betaine;
(8) Chloral hydrate;
(9) Chlordiazepoxide;
(10) Clobazam;
(11) Clonazepam;
(12) Clorazepate;
(13) Clotiazepam;
(14) Cloxazolam;
(15) Delorazepam;
(16) Dichloralphenazone (Midrin);
(17) Diazepam;
(18) Estazolam;
(19) Ethchlorvynol;
(20) Ethinamate;
(21) Ethyl loflazepate;
(22) Fludiazepam;
(23) Flunitrazepam;
(24) Flurazepam;
(25) Fospropofol (Lusedra);
(26) Halazepam;
(27) Haloxazolam;
(28) Ketazolam;
(29) Loprazolam;
(30) Lorazepam;
(31) Lormetazepam;
(32) Mebutamate;
(33) Medazepam;
(34) Meprobamate;
(35) Methohexital;
(36) Methylphenobarbital (mephorbarbital);
(37) Midazolam;
(38) Nimetazepam;
(39) Nitrazepam;
(40) Nordiazepam;
(41) Oxazepam;
(42) Oxazolam;
(43) Paraldehyde;
(44) Petrichloral;
(45) Phenobarbital;
(46) Pinazepam;
(47) Prazepam;
(48) Quazepam;
(49) Suvorexant;
(50) Temazepam;
(51) Tetrazepam;
(52) Triazolam;
(53) Zaleplon;
(54) Zolpidem;
(55) Zopiclone (Lunesta); and
(56) Brexanolone.
(c) Fenfluramine. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible: Fenfluramine.
(d) Stimulants. Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Cathine ((+)-norpseudoephedrine);
(2) Diethylpropion;
(3) Fencamfamin;
(4) Fenproporex;
(5) Mazindol;
(6) Mefenorex;
(7) Modafinil;
(8) Phentermine;
(9) Pemoline (including organometallic complexes and chelates thereof);
(10) Pipradrol;
(11) Sibutramine;
(12) SPA (1-dimethylamino-1,2-diphenylethane, lefetamine);
(13) Lorcaserin; and
(14) Solriamfetol.
(e) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its optical isomers and its salts, isomers, and salts of isomers:
(1) Pentazocine; and
(2) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid.
(f) The department of public safety may except by rule any compound, mixture, or preparation containing any depressant substance listed in subsection (b) or any stimulant listed in subsection (d) from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant or stimulant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the degree of danger or probable danger of the substances which have a depressant or stimulant effect on the central nervous system.
(g) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit;
(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane); and
(3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol). [L 1972, c 10, pt of §1; am L 1973, c 184, §1; am L 1974, c 217, §4; am L 1977, c 116, §3; am L 1978, c 68, §5; am L 1979, c 194, §3; am L 1980, c 140, §2; am L 1985, c 150, §3; am L 1987, c 203, §2; am L 1990, c 281, §10; am L 1993, c 9, §1; am L 1995, c 122, §4; am L 2000, c 98, §5; am L 2001, c 203, §5; am L 2002, c 165, §2; am L 2003, c 151, §5; am L 2006, c 171, §1; am L 2008, c 119, §5; am L 2010, c 123, §3; am L 2014, c 54, §3; am L 2015, c 195, §3; am L 2016, c 218, §4; am L 2021, c 233, §3]

Structure Hawaii Revised Statutes

Hawaii Revised Statutes

Title 19. Health

329. Uniform Controlled Substances Act

329-1 Definitions.

329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment.

329-3 Annual report.

329-4 Duties of the Hawaii advisory commission on drug abuse and controlled substances.

329-11 Authority to schedule controlled substances.

329-12 Nomenclature.

329-13 Schedule I tests.

329-14 Schedule I.

329-15 Schedule II tests.

329-16 Schedule II.

329-17 Schedule III tests.

329-18 Schedule III.

329-19 Schedule IV tests.

329-20 Schedule IV.

329-21 Schedule V tests.

329-22 Schedule V.

329-23 Republishing and distribution of schedules.

329-31 Rules.

329-31.5 Clinics.

329-32 Registration requirements.

329-33 Registration.

329-34 Revocation and suspension of registration.

329-35 Order to show cause.

329-36 Records of registrants.

329-37 Filing requirements.

329-38 Prescriptions.

329-38.2 Prescriptions; additional restrictions.

329-38.5 Opioid therapy; informed consent process; requirement for written policies.

329-39 Labels.

329-39.5 Opioid warning label.

329-40 Methadone treatment programs.

329-41 Prohibited acts B--penalties.

329-42 Prohibited acts C--penalties.

329-43 Penalties under other laws.

329-43.5 Prohibited acts related to drug paraphernalia.

329-43.6 Overdose prevention; limited immunity.

329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs.

329-45 REPEALED.

329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions.

329-49 Administrative penalties.

329-50 Injunctive relief.

329-51 Powers of enforcement personnel.

329-52 Administrative inspections.

329-53 Injunctions.

329-54 Cooperative arrangements and confidentiality.

329-55 Forfeitures.

329-56 Burden of proof; liabilities.

329-57 Judicial review.

329-58 Education and research.

329-59 Controlled substance registration revolving fund; established.

329-61 Substances subject to reporting.

329-62 Proper identification.

329-63 Person required to keep records and file reports.

329-64 Exceptions.

329-65 Penalty.

329-66 Theft, loss, and discrepancy reports.

329-67 Permit for conduct of business; applications; forms; fees; renewal; violations.

329-68 Protection of records; divulging confidential information prohibited; penalties.

329-69 Subpoena powers.

329-70 Forfeiture.

329-71 Requirements when selling specific chemicals.

329-72 Rules.

329-73 REPEALED.

329-74 Unlawful transport of pseudoephedrine.

329-75 Sales of products, mixtures, or preparations containing pseudoephedrine; reporting requirement for wholesalers.

329-81 to 91 REPEALED.

329-101 Reporting of dispensation of controlled substances; electronic prescription accountability system; requirements; penalty.

329-102 Central repository.

329-103 Designated state agency.

329-104 Confidentiality of information; disclosure of information.

329-121 Definitions.

329-122 Medical use of cannabis; conditions of use.

329-123 Registration requirements; qualifying patients; primary caregivers.

329-123.5 Registration requirements; qualifying out-of-state patient; caregiver of a qualifying out-of-state patient.

329-124 Insurance not applicable.

329-125 Protections afforded to a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient.

329-125.5 Medical cannabis patient and caregiver protections.

329-125.6 Protections afforded to an owner or qualified employee of a licensed medical cannabis dispensary.

329-126 Protections afforded to a treating physician or advanced practice registered nurse.

329-127 Protection of cannabis and other seized property.

329-128 Fraudulent misrepresentation; penalty.

329-129 Prohibited acts; flammable solvents.

329-130 Authorized sources of medical cannabis.

329-131 Prescription and pharmacy requirements not applicable.